The best indicator for Marsh McLennan (MRSH)
We backtested 20 indicators across daily, weekly and hourly charts on real Marsh McLennan (MRSH) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Money Flow Index
On the daily chart, this is the strongest risk-adjusted edge we found for Marsh McLennan (MRSH) over ~53.3 years — trailing buy-and-hold by 2.8% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Money Flow Index ✓ | Daily | 7.5% | 0.56 | -60.8% | 84.2% | 57 | -2.8% |
| 2 | Holy Grail Confluence ✓ | Weekly | 5.4% | 0.51 | -25.9% | 100.0% | 15 | -4.9% |
| 3 | CCI ✓ | Weekly | 6.2% | 0.49 | -36.5% | 87.5% | 56 | -4.1% |
| 4 | Williams %R ✓ | Weekly | 6.0% | 0.46 | -38.2% | 84.9% | 73 | -4.2% |
| 5 | Holy Grail Confluence ✓ | Daily | 5.6% | 0.44 | -60.1% | 79.8% | 84 | -4.7% |
| 6 | WaveTrend (8/6/4) ✓ | Daily | 6.4% | 0.43 | -64.6% | 68.8% | 205 | -3.9% |
| 7 | EMA 20/50 Cross ✓ | Weekly | 6.8% | 0.43 | -67.1% | 45.0% | 20 | -3.4% |
| 8 | Bollinger Mean-Reversion ✓ | Weekly | 4.5% | 0.43 | -28.9% | 77.5% | 40 | -5.7% |
| 9 | Stochastic ✓ | Weekly | 5.8% | 0.43 | -54.5% | 84.5% | 58 | -4.4% |
| 10 | WaveTrend (8/6/4) ✓ | Weekly | 4.9% | 0.39 | -34.3% | 85.4% | 41 | -5.3% |
| 11 | EMA 50/200 Cross ✓ | Daily | 4.8% | 0.34 | -72.3% | 33.3% | 39 | -5.5% |
| 12 | SMA 50/200 Cross ✓ | Daily | 4.8% | 0.34 | -71.3% | 47.5% | 40 | -5.5% |
| 13 | EMA 20/50 Cross ✓ | Daily | 4.5% | 0.34 | -71.9% | 39.5% | 124 | -5.8% |
| 14 | Stochastic ✓ | Daily | 4.2% | 0.34 | -67.5% | 71.3% | 268 | -6.1% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Marsh McLennan (MRSH), Money Flow Index on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.